Short Interest in Diversified Healthcare Trust – (NASDAQ:DHCNI) Rises By 190.2%

Diversified Healthcare Trust – (NASDAQ:DHCNI) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 54,805 shares, an increase of 190.2% from the June 15th total of 18,882 shares. Based on an average daily trading volume, of 39,049 shares, the short-interest ratio is currently 1.4 days.

Diversified Healthcare Trust Trading Down 2.1%

DHCNI stock traded down $0.38 during trading on Wednesday, hitting $17.91. 246 shares of the company traded hands, compared to its average volume of 65,815. The company has a 50-day moving average of $18.30 and a 200-day moving average of $17.64. Diversified Healthcare Trust has a 1 year low of $15.61 and a 1 year high of $19.09.

Diversified Healthcare Trust Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, August 1st. Stockholders of record on Wednesday, July 15th will be paid a dividend of $0.3516 per share. This represents a $1.41 dividend on an annualized basis and a dividend yield of 7.9%. The ex-dividend date of this dividend is Wednesday, July 15th.

Diversified Healthcare Trust (NASDAQ: DHCNI) is a publicly traded real estate investment trust (REIT) specializing in healthcare and life science properties. The company’s primary business activities include the acquisition, development, ownership and management of net‐leased medical office buildings, senior housing facilities and life science research and development assets. In addition to property investments, Diversified Healthcare Trust holds mortgage loans and preferred equity interests in the healthcare sector, offering diversified exposure to both real estate and structured financing arrangements.

The company’s portfolio spans a broad range of healthcare asset types, including medical office buildings leased to health systems and physician groups, senior living communities operated by leading care providers, and life science campuses serving biotechnology and pharmaceutical companies.